Clinical Trials List
Protocol Number103-2566A
2014-08-01 - 2019-07-31
Others
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Tzu-Chen Yen Division of Nuclear Medicine
- Chia-Hsun Hsieh Division of Hematology & Oncology
- 徐潤德 Division of General Surgery
- 曾振輝 Division of Radiology
- Jen-Shi Chen Division of Hematology & Oncology
- Yu-Chuan Chang Division of Nuclear Medicine
- Wen-Chi Chou Division of Hematology & Oncology
- Shih-Hsin Chen Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0 participants
-
Global
36 participants
